5940
J. Gaire et al. / Tetrahedron 68 (2012) 5935e5941
DMSO-d6) 9.16 (2H, s, pyz-H), 3.56 (2H, br s, NH); dC (75 MHz,
DMSO-d6) 150.3 (CN4), 146.1, 139.8.
125.2, 52.9 (CH2N), 29.1, 25.7; HRMS (ES): [Mþ1]þ, found 671.3543.
C34H39N16 requires 671.3544.
4.3. 2-(60-Bromohexyl)-5-phenyl-2H-tetrazole (4)
4.5.2. 5-Phenyl-2-(6-(5-(3-(1-(6-(5-phenyl-2H-tetrazol-2-yl)hexyl)-
1H-tetrazol-5-yl)phenyl)-2H-tetrazol-2-yl)hexyl)-2H-tetrazole
(8). White solid (0.35 g, 23%), mp 111e114 ꢀC. Found: C, 60.84; H,
5.68; N, 33.42. C34H38N16 requires C, 60.88; H, 5.71; N, 33.41%; Rf
(99:1 chloroform/methanol) 0.48; nmax (KBr) 2927, 2855, 1618,
To 5-phenyl-1H-tetrazole (1.00 g, 6.80 mmol) dissolved in ace-
tonitrile (30 mL) was added potassium carbonate (9.40 g,
68.0 mmol). The resulting suspension was stirred at reflux for
30 min and to the hot solution was added 1,6-dibromohexane
(6.10 g, 25.0 mmol). The reaction mixture was then stirred at
reflux temperature for a further 24 h. After cooling and removal of
inorganic solids, the solvent was removed under reduced pressure
to afford an oil, which was purified by column chromatography on
silica gel (initially at a ratio of petroleum ether/ethyl acetate 4:1,
followed by the ratio of 3:2) to give a waxy white solid (3.2 g, 50%),
mp 42e44 ꢀC. Found: C, 50.46; H, 5.51; N, 18.09. C13H17BrN4 re-
quires C, 50.50; H, 5.54; N, 18.12%; Rf (3:2 petroleum ether/ethyl
1528, 1465, 1261 cmꢁ1
; dH (300 MHz, CDCl3) 8.44 (1H, s, PheH),
8.36 (1H, d, J¼7.7 Hz, PheH), 8.13 (4H, d, J¼7.7 Hz, PheH), 7.80 (1H,
d, J¼7.8 Hz, PheH), 7.69 (1H, t, J¼7.8 Hz, PheH), 7.48e7.46 (6H, m,
PheH), 4.65 (6H, t, J¼7.1 Hz, CH2N2), 4.48 (2H, t, J¼7.2 Hz, CH2N1),
2.06e2.05 (8H, m, CH2), 1.41e1.40 (8H, m, CH2); dC (75 MHz, CDCl3)
165.5 (CN4), 163.6 (CN4), 153.9 (CN4), 130.5, 130.3, 129.4, 128.9,
128.7, 127.4, 126.8, 126.7, 53.1 (CH2N2), 52.8 (CH2N2), 47.9 (CH2N1),
29.0, 25.7; HRMS (ES): [Mþ1]þ, 671.3545. C34H39N16 requires 671.
3544.
acetate) 0.74; nmax (KBr) 2957, 2855,1663,1514,1458,1255 cmꢁ1
; dH
(300 MHz, CDCl3) 8.15 (2H, br d, AreH), 7.48e7.45 (3H, m, AreH),
4.66 (2H, t, J¼7.0 Hz, CH2N), 3.37 (2H, t, J¼6.2 Hz, CH2Br), 2.08e2.06
(2H, m, CH2), 1.85e1.83 (2H, m, CH2), 1.41e1.39 (4H, m, CH2); dC
(75 MHz, CDCl3) 164.9 (CN4), 130.2, 128.9, 127.4, 126.7, 52.9 (CH2N),
33.5 (CH2Br), 32.3, 29.1, 27.4, 25.5.
4.6. 2-(2-(6-(5-(3-(2-(6-(5-(Pyridin-2-yl)-2H-tetrazol-2-yl)
hexyl)-2H-tetrazol-5-yl)phenyl)-2H-tetrazol-2-yl)-2H-
tetrazol-5-yl))pyridine (9)
Compound 1 (0.10 g, 0.06 mmol) was dissolved in acetonitrile
(50 mL). To this was added triethylamine (0.30 mL, 0.16 mmol).
The resulting solution was stirred at reflux for 30 min and to the
hot solution 5 (0.40 g, 0.18 mmol) was added and heating was
continued for a further 24 h. After cooling and removal of in-
organic solids, the solvent was removed under reduced pressure
to afford a yellow oil, which was then purified by column chro-
matography on silica gel (initially at a ratio of chloroform/meth-
anol 99:1, followed by the ratio 19:1). This gave the product 9 as
a white solid (0.12 g, 28%), mp 88e90 ꢀC. Found: C, 57.23; H, 5.41;
N, 37.23. C32H36N18 requires C, 57.13; H, 5.39; N, 37.48%; Rf (19:1
chloroform/methanol) 0.54; nmax (KBr) 2965, 2851, 1629, 1515,
4.4. 2-(600-Bromohexyl-(2-tetrazol-5-yl))pyrazine (6)
To 2-(1H-tetrazol-5-yl)pyrazine (1.00 g, 6.80 mmol) dissolved in
acetonitrile (30 mL) was added potassium carbonate (9.40 g,
68.0 mmol). The resulting suspension was stirred at reflux for
30 min and to the hot solution was added 1,6-dibromohexane
(6.10 g, 25.0 mmol). The reaction mixture was then stirred at
reflux temperature for a further 24 h. After cooling and removal of
inorganic solids, the solvent was removed under reduced pressure
to afford an oil, which was purified by column chromatography
on silica gel (initially at a ratio of petroleum ether/ethyl acetate 4:1,
followed by the ratio of 3:2). This gave the product 6 as a clear
oil (0.55 g, 26%). Found: C, 42.53; H, 4.91; N, 26.95. C11H15BrN6
requires C, 42.46; H, 4.86; N, 27.01%; Rf (3:2 petroleum ether/ethyl
1452, 1249 cmꢁ1
; dH (300 MHz, CDCl3) 8.92 (1H, s, PheH), 8.78
(2H, d, J¼7.7 Hz, pyr-H), 8.26 (2H, d, J¼7.7 Hz, pyr-H), 8.23 (2H, d,
J¼7.7 Hz, PheH), 7.89 (2H, t, J¼7.7 Hz, pyr-H), 7.62 (1H, t, J¼7.8 Hz,
PheH), 7.41 (2H, t, J¼7.7 Hz, pyr-H), 4.69 (8H, t, J¼6.9 Hz, CH2N),
2.11e2.10 (8H, m, CH2), 1.46e1.45 (8H, m, CH2); dC (75 MHz,
CDCl3) 164.8 (CN4), 164.6 (CN4), 150.3, 146.8, 137.1, 129.5, 128.5,
128.2, 125.2, 124.8, 122.0, 53.2 (CH2N), 52.9 (CH2N), 29.0, 25.7;
HRMS (ES): [Mþ1]þ, found 673.3444. C32H37N18 requires
673.3448.
acetate) 0.29; nmax (KBr) 2956, 1663, 1514, 1458, 1255 cmꢁ1
; dH
(300 MHz, CDCl3) 9.62 (1H, s, pyz-H), 8.73 (2H, br d, pyz-H), 4.94
(2H, t, J¼6.9 Hz, CH2N), 3.37 (2H, t, J¼6.2 Hz, CH2Br), 2.02e2.00 (2H,
m, CH2), 1.70e1.68 (2H, m, CH2), 1.42e1.40 (4H, m, CH2); dC
(75 MHz, CDCl3) 162.6 (CN4), 146.2, 145.7, 143.7, 141.8, 49.6 (CH2N),
33.7 (CH2Br), 32.4, 29.7, 27.5, 25.5.
4.7. Preparation of pyridyl macromolecules (10 and 11)
4.5. Preparation of phenyl macromolecules (7 and 8)
Compound 2 (1.40 g, 1.78 mmol) was dissolved in acetonitrile
(50 mL) and to this was added triethylamine (1.20 mL, 8.90 mmol).
The resulting solution was stirred at reflux for 30 min and to this
was added 5 (1.70 g, 5.35 mmol). The solution was then refluxed for
24 h. After cooling, the solvent was removed under reduced pres-
sure to afford a yellow oil, which was then purified by column
chromatography on silica gel using the ratio of chloroform/meth-
anol (99:1).
Compound 1 (0.50 g, 2.30 mmol) was dissolved in acetonitrile
(50 mL). To this was added triethylamine (1.50 mL, 11.0 mmol). The
resulting solution was stirred at reflux for 30 min and to the hot
solution 4 (2.10 g, 7.00 mmol) was added and heating was contin-
ued for a further 24 h. After cooling, the solvent was removed under
reduced pressure to afford a yellow oil, which was then purified by
column chromatography on silica gel (initially at the ratio of chlo-
roform/methanol 99:1, followed by the ratio 95:5).
4.7.1. 2-(2-(6-(5-(6-(2-(6-(5-(Pyridine-2-yl)-2H-tetrazol-2-yl)
hexyl)-2H-tetrazol-5-yl)pyridin-2-yl)-2H-tetrazol-1-yl)hexyl)-2H-
tetrazol-5-yl)pyridine (10). White solid (0.10 g, 8%); mp
132e135 ꢀC. Found: C, 55.22; H, 5.28; N, 39.48. C31H35N19 requires
C, 55.26; H, 5.24; N, 39.50%; Rf (99:1 chloroform/methanol) 0.70;
4.5.1. 5-Phenyl-2-(6-(5-(3-(2-(6-(5-phenyl-2H-tetrazol-2-yl)hexyl)-
2H-tetrazol-5-yl)phenyl)-2H-tetrazol-2-yl)hexyl)-2H-tetrazole
(7). White solid (0.63 g, 41%), mp 107e109 ꢀC. Found: C, 60.75; H,
5.73; N, 33.44. C34H38N16 requires C, 60.88; H, 5.71; N, 33.41%; Rf
(99:1 chloroform/methanol) 0.30; nmax (KBr) 2920, 2851, 1648,
nmax (KBr) 2952, 1651, 1593, 1466, 1418, 1263 cmꢁ1
; dH (300 MHz,
1527, 1465, 1263 cmꢁ1
;
dH (300 MHz, CDCl3) 8.93 (1H, s, PheH),
CDCl3) 8.78 (2H, d, J¼7.7 Hz, pyr-H), 8.35 (2H, d, J¼7.6 Hz, pyr-H),
8.26 (2H, d, J¼7.7 Hz, pyr-H), 8.05 (1H, t, J¼7.7 Hz, pyr-H), 7.87
(2H, t, J¼7.7 Hz, pyr-H), 7.40 (2H, br t, pyr-H), 4.72 (8H, t, J¼6.9 Hz,
CH2N), 2.10e2.09 (8H, m, CH2), 1.44e1.43 (8H, m, CH2); dC (75 MHz,
CDCl3) 165.0 (CN4), 164.4 (CN4), 150.3, 147.5, 146.8, 138.3, 137.1,
8.26 (2H, d, J¼7.7 Hz, PheH), 8.13 (4H, d, J¼7.7 Hz, PheH), 7.64 (1H,
t, J¼7.7 Hz, PheH), 7.47e7.46 (6H, m, PheH), 4.66 (8H, t, J¼7.0 Hz,
CH2N), 2.09e2.08 (8H, m, CH2), 1.46e1.45 (8H, m, CH2); dC (75 MHz,
CDCl3) 165.1 (CN4), 130.3, 129.6, 128.9, 128.5, 128.2, 127.4, 126.8,